SCHEMBL7419260

SCHEMBL7419260

N#Cc1ccc(CCN(C(=O)C(C(N)=O)C2CCCCC2)C2CCNCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.47
SLC6A2 P23975 4/20 0.41
SLC6A4 P31645 4/20 0.41
MAPKAPK2 P49137 1/20 0.38
NSD2 O96028 1/20 0.37
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CTSC P53634 6/20 0.35
KCNH2 Q12809 3/20 0.35
CCR5 P51681 1/20 0.34
SLC6A3 Q01959 2/20 0.34
MBTPS1 Q14703 1/20 0.34
CTSK P43235 1/20 0.33
EP300 Q09472 1/20 0.33
DPP4 P27487 1/20 0.33
FAP Q12884 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7411444 0.83 EPHX1 (0.48) EPHX1SLC6A2SLC6A4KCNH2SLC6A3
SCHEMBL7014601 0.75 EPHX1 (0.50) EPHX1SLC6A2SLC6A4KCNH2SLC6A3
SCHEMBL7420047 0.67 SLC6A4 (0.34) SLC6A2SLC6A4KCNH2SLC6A3
SCHEMBL7021841 0.67 SLC6A2 (0.36) SLC6A2SLC6A4KCNH2SLC6A3
SCHEMBL7019871 0.66 SLC6A2 (0.36) SLC6A2SLC6A4KCNH2SLC6A3
Hydrochloric Acid SCHEMBL7137781 0.65 HTR2A (0.45) SLC6A2SLC6A4MAPKAPK2NSD2RAB9A
SCHEMBL7420833 0.65 L3MBTL1 (0.41) EPHX1CTSK
SCHEMBL6382622 0.65 CYP2C9 (0.53) EPHX1NPC1RAB9ACTSCKCNH2
SCHEMBL6382625 0.65 CYP2C9 (0.53) EPHX1NPC1RAB9ACTSCKCNH2
SCHEMBL6379276 0.65 CYP2C9 (0.53) EPHX1NPC1RAB9ACTSCKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed